Overview
Swiss diagnostics division of Roche Group. Blood glucose, molecular diagnostics, and tissue diagnostics. Public company (SWX: ROG).
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
Focus
Stage
HQ
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Partnerships
Every company Roche Diagnostics has built with, alongside the ones only announced in a press release.
Roche Diagnostics on the deployment map
View the global mapRoche Diagnostics has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Roche Diagnostics on the DEPLOY record yet. Track Roche Diagnostics to know the moment the first one is verified.
Relationships
Current leadership (1)
- Thomas Schinecker CEOsecondary-verified
Media (1)
Company-anchored media. Official assets the company has published at the company level, distinct from model-anchored media that lives on individual product pages.
Safety record
No incidents on record for Roche Diagnostics.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Roche Diagnostics in third-party press
Partnerships
2 total · 2 operating
Every company Roche Diagnostics has built with, alongside the ones only announced in a press release.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJul 23, 2026
Roche Diagnostics logo
- Record createdJun 8, 2026
Added to the verified registry
Sources (1)
Common questions
What is Roche Diagnostics?
What does Roche Diagnostics make?
Is Roche Diagnostics publicly traded?
Who is the CEO of Roche Diagnostics?
How can I invest in Roche Diagnostics?
Where is Roche Diagnostics headquartered?
Who owns Roche Diagnostics?
Where does Roche Diagnostics operate robots?
Is Roche Diagnostics a top robotics company?
When was Roche Diagnostics founded?
Is Roche Diagnostics safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-09-06
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-09-06
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Roche Diagnostics.In the press
Recent coverage mentioning Roche Diagnostics from third-party publications. Automatically surfaced; not part of the verified registry record.
Roche Turns To Industrial Robotics Partner ABB Robotics In Lab Automation Push
ABB Robotics Partners With Roche Diagnostics
ABB Robotics collaborates with Roche to bring physical AI to laboratories
Roche Diagnostics Announces India Leadership Transition, Names Marco Valencia Sanchez as General Manager
Roche to acquire PathAI for up to $1.05bn
Roche To Acquire PathAI, Signaling Intensifying AI Diagnostics Race
CK Birla Hospital®, Delhi Becomes North India's First Centre to Complete 50 Robot-Assisted Breast Cancer Surgeries
Diagnostic Testing Market Size Reaches New Heights: Forecast to Reach USD 272.98 Billion by 2034 Driven by Advanced Screening Technologies and Point-of-Care Expansion
Roche Diagnostics Growth Flattens As China Reforms Bite; Bets On US Manufacturing, CGM For Growth
Roche Diagnostics Day 2025: ‘We Need To Become A Leader In Decentralized Testing’
AUTOMA+ 2025
Meet the Women of Our Engineering and Maker World
Machine-readable surfaces
- Markdown mirror: /companies/roche-diagnostics.md
- RSS feed: /companies/roche-diagnostics/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/1c605345-f334-4204-a83b-044eaef6f5c4
- Revision history: /companies/roche-diagnostics/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Heat Index
Serious54/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Roche Diagnostics draws attention at the 43rd percentile but verifies reality at the insufficient-data level among other robots.
6-month trend
Analysis
Limited public visibility and press coverage relative to peers.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Nov 5, 2026